Product Information
LINEZOLID 600 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.4946 per EA under NDC 59762130701. Its NADAC has been published 538 times since Feb 3, 2016.
FDA first approved this application on Apr 18, 2000.
Strength
600 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762130701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
LINEZOLIDApproval Type
Authorized Generic (NDA)
FDA Application
NDA021130FDA Approved
4/18/2000
On Market Since
10/12/2015
Pharmacological Classes
Price Statistics
The NADAC for LINEZOLID 600 MG TABLET has been published 538 times since Feb 3, 2016, and over the history we have for it it has declined 98.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4946 per EA |
|---|---|
| All-time high | $131.3380 (Feb 10, 2016) |
| All-time low | $1.2559 (Nov 20, 2024) |
| 52-week high | $1.5539 |
| 52-week low | $1.3676 |
| Median price | $2.1369 |
| Average price | $4.1441 |
| Largest weekly change | -88.2% (Mar 23, 2016) |
| Weeks tracked | 538 |
| Tracking since | Feb 3, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
+8.5%
1Y
+1.9%
3Y
-20.0%
5Y
-33.6%
All
-98.9%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
linezolid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Oxazolidinone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LINEZOLID 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LINEZOLID 600 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $1.4946 per EA (NDC 59762130701), effective May 20, 2026.
How has the price of LINEZOLID 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for LINEZOLID 600 MG TABLET has declined 98.9%. It has been tracked across 538 weekly CMS publications since Feb 3, 2016.
What are the highest and lowest recorded NADAC prices for LINEZOLID 600 MG TABLET?
Since Feb 3, 2016, the NADAC for LINEZOLID 600 MG TABLET has ranged from a low of $1.2559 (Nov 20, 2024) to a high of $131.3380 (Feb 10, 2016), with a median of $2.1369 per EA.
Are there cheaper alternatives to LINEZOLID 600 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LINEZOLID 600 MG TABLET, is $1.3818 per EA — about 8% below LINEZOLID 600 MG TABLET.
Who manufactures LINEZOLID 600 MG TABLET?
LINEZOLID 600 MG TABLET (NDC 59762130701) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.